These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9260732

  • 1. Phenytoin kinetics in Japanese adult epileptics: phenotype of phenytoin slow metabolizers.
    Watanabe M, Iwahashi K, Kugoh T, Suwaki H.
    Clin Neuropharmacol; 1997 Aug; 20(4):346-51. PubMed ID: 9260732
    [Abstract] [Full Text] [Related]

  • 2. The relationship between phenytoin pharmacokinetics and the CYP2C19 genotype in Japanese epileptic patients.
    Watanabe M, Iwahashi K, Kugoh T, Suwaki H.
    Clin Neuropharmacol; 1998 Aug; 21(2):122-6. PubMed ID: 9579299
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A, Hashimoto Y, Takayanagi K, Otsuki Y, Koue T, Takano M, Yasuhara M, Hattori H, Furusho K, Inui K.
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [Abstract] [Full Text] [Related]

  • 4. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.
    Mamiya K, Ieiri I, Shimamoto J, Yukawa E, Imai J, Ninomiya H, Yamada H, Otsubo K, Higuchi S, Tashiro N.
    Epilepsia; 1998 Dec; 39(12):1317-23. PubMed ID: 9860067
    [Abstract] [Full Text] [Related]

  • 5. Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach.
    Yukawa E, Mamiya K.
    J Clin Pharm Ther; 2006 Jun; 31(3):275-82. PubMed ID: 16789993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.
    Alqahtani S, Alzaidi T, Alotaibi M, Alsultan A.
    Pharmacology; 2019 Jun; 104(1-2):60-66. PubMed ID: 31067540
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors influencing the population pharmacokinetic parameters of phenytoin in adult epileptic patients in South Africa.
    Valodia P, Seymour MA, Miller R, McFadyen ML, Folb PI.
    Ther Drug Monit; 1999 Feb; 21(1):57-62. PubMed ID: 10051055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of acute phase response on phenytoin metabolism in neurotrauma patients.
    McKindley DS, Boucher BA, Hess MM, Rodman JH, Feler C, Fabian TC.
    J Clin Pharmacol; 1997 Feb; 37(2):129-39. PubMed ID: 9055139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single oral loading dose of phenytoin: a pharmacokinetics study.
    Ratanakorn D, Kaojarern S, Phuapradit P, Mokkhavesa C.
    J Neurol Sci; 1997 Mar 20; 147(1):89-92. PubMed ID: 9094065
    [Abstract] [Full Text] [Related]

  • 19. Ticlopidine inhibits phenytoin clearance.
    Donahue S, Flockhart DA, Abernethy DR.
    Clin Pharmacol Ther; 1999 Dec 20; 66(6):563-8. PubMed ID: 10613611
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.